Prothena Corporation plc

Available to platforms
R StocksTrader
Prothena Corporation is a company with experience in studying diseases related to protein metabolism dysregulation, with its drugs in the final stages of clinical trials. The portfolio includes a number of experimental drugs capable of altering the course of rare severe neurodegenerative diseases and neuropathies caused by amyloid infiltration of peripheral nerves. The company is developing several drugs for the treatment of Alzheimer's disease, including in collaboration with Bristol-Myers Squibb, as well as for Parkinson's disease and others.

Prothena Corporation plc - PRTA stocks live chart

Analyze price movements of Prothena Corporation plc online with R StocksTrader stock charts. You don't need to refresh chart as the quotes are updated automatically. View the current and previous PRTA quotes, get all necessary information for adding Prothena Corporation plc to your investment portfolio.

You can invest in Prothena Corporation plc and real stocks and CFDs on stocks of other American and European companies in R StocksTrader. Stocks, Indices, Metals: 12,000 assets in total are available for trading in the web terminal. Explore price movements of popular assets, like Prothena Corporation plc, in our "Charts" section and expand your trading opportunities by investing in new instruments.

Risk Warning: past performance of PRTA does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Prothena Corporation plc (PRTA).

You can trade Prothena Corporation plc (PRTA) on the R StocksTrader platform.

You can trade online Prothena Corporation plc (PRTA) on Prime, ECN, Pro, or R StocksTrader accounts.